Authors: Frazier, JA Biederman, J Tohen, M Feldman, PD Jacobs, TG Toma, V Rater, MA Tarazi, RA Kim, GS Garfield, SB Sohma, M Gonzalez-Heydrich, J Risser, RC Nowlin, ZM

Citation: Ja. Frazier et al., A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder, J CH AD PSY, 11(3), 2001, pp. 239-250

Authors: Jarrett, RB Schaffer, M McIntire, D Witt-Browder, A Kraft, D Risser, RC

Citation: Rb. Jarrett et al., Treatment at atypical depression with cognitive therapy or phenelzine - Inreply, ARCH G PSYC, 57(11), 2000, pp. 1084-1085

Authors: Weiner, MF Vega, G Risser, RC Honig, LS Cullum, CM Crumpacker, D Rosenberg, RN

Citation: Mf. Weiner et al., Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease, BIOL PSYCHI, 45(5), 1999, pp. 633-638

Authors: Jarrett, RB Schaffer, M McIntire, D Witt-Browder, A Kraft, D Risser, RC

Citation: Rb. Jarrett et al., Treatment of atypical depression with cognitive therapy or phenelzine - A double-blind, placebo-controlled trial, ARCH G PSYC, 56(5), 1999, pp. 431-437

Authors: Brown, DF Dababo, MA Bigio, EH Risser, RC White, CL

Citation: Df. Brown et al., The Lewy body variant of Alzheimer disease represents combined Alzheimer disease and Parkinson disease pathology, RESEARCH AND PRACTICE IN ALZHEIMER'S DISEASE, VOL 2, 1999, pp. 225-229

Authors: Weiner, MF Risser, RC

Citation: Mf. Weiner et Rc. Risser, Effect of educational attainment on survival in Alzheimer's disease, ALZHEIM REP, 1(6), 1998, pp. 369-374